Polskie Radio reports Novo Nordisk will offer Wegovy in vials, a new format alongside the familiar injection pens.
Recap by typeshit. Full story at www.polskieradio.pl.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Polskie Radio covers the FDA clearing Lilly's Zepbound to treat obstructive sleep apnea, an earlier approval beyond weight loss.
Horek told KXAN he went on Wegovy hoping to drop a few stubborn pounds. Months later his story took a turn worth reading in full.
Loading…